GenMont Biotech Incorporation (3164.TW) TAI

19.90

+0.1(+0.51%)

Updated at August 19 01:34PM

Currency In TWD

Valuation

Market Cap1.75B
Enterprise Value1.76B
P/E Ratio44.13
PEG Ratio-1.41
Price/Sales Ratio4.65
Price/Book Ratio1.31
Enterprise/Revenue4.57
Enterprise/EBITDA14.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.11
Operating Margin0.07

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue385.37M
Revenue/Share4.25
Gross Profit238.18M
EBITDA140.03M
Net Income57.25M
Diluted EPS0.7

Balance Sheet

Total Cash457.01M
Total Cash/Share5.28
Total Debt114.49M
Total Debt/Equity0.09
Current Ratio2.58
Book Value Per Share16.62

Price History

52-Week Change-12.56
52-Week High24
52-Week Low17.2
Moving Average 50 Days20.45
Moving Average 200 Days20.33

Statistics

Average Volume24,114
Shares Outstanding86.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield4.03
Payout Ratio1.11
Last Split Factor11:10
Last Split DateJune 15, 2010